AMGN · News · 20260902N
Revenue Performance and Mix
AMGEN INC · 2026-09-02 · Importance 24 · Surprise 14 · In source text
Amgen reported second-quarter 2026 revenue of $10.05 billion, exceeding analyst estimates. Revenue increased 9.5% year over year. Adjusted EPS was $6.29 for the quarter, also above expectations. The reported growth was attributed to performance from six key growth products, although no product-level revenue breakdown was provided.
Key facts
- Amgen reported Q2 adjusted EPS of $6.29 and revenue of $10.05 billion. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | — | Amgen reported Q2 adjusted EPS of $6.29 and revenue of $10.05 billion. |
| net_income | positive | realized | — | Amgen reported Q2 adjusted EPS of $6.29 and revenue of $10.05 billion. |